(‘AfriAg’ or the ‘Company’)
First production of licensed legal medical cannabis oils for commercial sale in
Apollon, with its new State-of-the-Art Licensed Processing Facility in operation, will now focus on using its medical cannabis oil to produce medical cannabis products and pharmaceuticals for retail sales.
-- Apollon’s State-of-the-Art
Processing Labis capable of producing large commercial amounts of medical cannabis oils and extracts. Extraction of medical oils has now begun, with efforts now focused upon the production of the first medical cannabis products to be available for use and sale in the company’s CLA Retail (Therapeutic Services) Licensed dispensary located on the premises of the Doc’s Place Wellness Resortin Negril, Jamaica. -- Apollon medical service staff has been extended to include Dr. MarjorieVassell and Dr. Alfred Dawes. -- Apollon Cannabis Collective has been established. This collective is a commercial platform to facilitate and engage local farmers to grow medical cannabis crop for processing by Apollon at its licensed facilities, giving Apollon access to additional growers and land and reinforcing Apollon’s commitment to working with Jamaican farmers and businesses. -- Continued work is underway by Apollon towards Tier 3 cultivation licence approval.
“Apollon is developing its fully vertically integrated medical cannabis business in
As previously announced,
Apollon is a Federally Licensed vertically integrated medical cannabis company operating in
Notice Regarding Forward-Looking Statements
This announcement includes "forward-looking statements" involving the Company, the other entities referenced in this announcement, and the respective subsidiaries, affiliates and associates of the Company and such other entities (collective, the “Involved Entities”), which include all statements other than statements of historical facts, including, without limitation, those regarding the financial position, business strategy, plans and objectives of management for future operations, and any statements preceded by, followed by or that include forward-looking terminology such as the words "targets", "believes", "estimates", "expects", "aims", "intends", "will", "can", "may", "anticipates", "would", "should", "could" or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the control of the Involved Entities that could cause the actual results, performance or achievements of the Involved Entities to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the present and future business strategies of the Involved Entities and the environment in which the Involved Entities will operate in the future. These forward-looking statements speak only as of the date of this announcement. The Company, on behalf of itself and each of the Involved Entities, expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in expectations of any Involved Entities with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, readers are cautioned not to rely on any forward-looking statement.
The directors of the Company accept responsibility for the contents of this announcement.
For further information on AfriAg Global please visit the www.afriagglobal.com or please contact;
+44 (0)20 7440 0640
+44 (0)20 7469 0930